Under construction – not a live service
Sign in

2024-514549-12-00RecruitingPhase 4

The use of therapeutic monitoring of ocrelizumab serum concentrations for personalized pharmacotherapy of relapsing-remitting and primary progressive multiple sclerosis

Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Next steps

Brief summary (registry, in English)

To determine whether and how serum OCR concentrations correlate with selected paraclinical and clinical indicators in patients with relapsing-remitting and/or primary progressive MS

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
First submitted
7 Jun 2024
Start date
16 Jun 2025
Lead sponsor
Fakultni Nemocnice Ostrava
EU CT number
2024-514549-12-00

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 100
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Hypersensitivity to the medicinal substance or to any excipient
  • Current active infection
  • Known active malignant disease

Other

  • Patients in a severe immunocompromised state
  • Pregnancy or breastfeeding

Who the study is looking for

  • Patients diagnosed with RR and/or PP RS with already established or newly started OCR treatment
  • Men and women older than 18 years
  • Signing the Informed Consent to participate in the study
  • Female patients of childbearing age who can become pregnant must have a negative result of serum human chorionic gonadotropin (hCG) at the initial visit and use a highly reliable method of contraception with a home control urine pregnancy test every month for the entire duration of the study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Fakultni nemocnice OstravaOstravaCzechiaRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.